Download Referencias bibliográficas - BVS Cuba
Transcript
RCP 4-03 Referencias bibliográficas T-1 Referencias bibliográficas 1. Rangel M. Complicaciones cardiacas en la insuficiencia renal crónica en: Hernardo Avendaño L. Nefrología Clínica. Ed. Médica Panamericana, 1998. 2. Orejas G, Cobo A. Fallo renal crónico. Generalidades En: García Nieto V, Santos F. eds. Madrid: Grupo de Aula Médica S.A. Nefrología Pediátrica, 2000: 279-83. 3. Nicholls AJ. Corazón y circulación: En Dougerdes JT. Manual de Diálisis. Masson Litles Brown, 1996: 585-601. 4. López Gómez JM, Jofre R, Cases A. Cardiovascular risk factors in chronic renal failure. Nefrología 2002; 22 suppl.1: 59-67. 5. Cases A, Vera M, López Gómez JM. Cardiovascular risk in patients with crhonic renal failure. Patients in renal replacement therapy. Nefrología 2002; 22 suppl 1: 68 -74. 6. Saland JM, Ginsberg H, Fisher EA. Dyslipidemia in pediatric renal disease: Epidemiology, pathophysiology and management. Curr Opin Pediatr 2002; 14:197-204. 7. Levin A, Stevens L, Mc Cullough PA. Cardiovascular disease and the kidney. Tracking a killer in chronic kidney disease. Postgrad Med 2002; 111:53-60. 8. Fernández Andrade C. Renal markers and predictors in renal and cardiovascular risk factors. Nefrología 2002; 22 suppl 1:2 -29. 9. Obrador GT, Pereira BJ. Systemic complications of chronic kidney disease. Postgrad Med 2002; 111:115-22. 10. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, Burke Sk, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002; 20:39. 11. Tazawa M, Iseki K, Iseki C, Takishita S. Pulse Pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Kidney Int 2002; 61:717- 26. 12. Mathur S, Devaraj S, Jialal L. Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr Opin Nephrol. Hypertens 2002; 11:141-7. 13. Jacobson Sh, Egberg N, Hylander B, Lundahl J. Correlation between soluble markers of endothelial dysfunction in patients with renal failure. Am J Nephrol 2002; 22:42. 14. Ivens K, Gradaus F, Heering P, Schoebel FC, Klein M. Schulte HD, et al. Myocardial revascularization in patients with end-stage renal disease: comparison of percutaneous transluminal coronary angioplasty and coronary artery bypass grafting. Int Urol. Nephrol 2001; 32:717-23. 15. Dikow R, Zeier M, Ritz Z. Cardiovascular abnormalities and hypertension in the elderly dialysis patients. Semin Dial 2002;15:121-6. 16. Atalay S, Ekim M, Tutar HE, Kocak G, Bakkaloglu S, Turner N. Systolic and diastolic function in children with chronic renal failure. Pediatr Int 2002; 44:18-23. 17. London GM, Uremic cardiomyopathy. An inadequate left ventricular hypertrophy. Kidney Int 1987; 31: 973-8. 18. Foley RN Left ventricular hypertrophy in dialysis patients. Semin Dial 1992; 5:34-9. 19. Cressman MD. Lipoprotein in an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992; 86:475-9. 20. D’Amico G, Sanna G. Symposium on lipid abnormalities in renal disease. Kidney Int 1999(suppl); 31: 51. Recibido: 1 de agosto de 2003. Aprobado: 29 de septiembre de 2003. Dra. Neri G. Campañá Cobas. Hospital Pediátrico Universitario “William Soler”, San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba. T-2 Referencias bibliográficas 1. Williams H, Johson K.Imaging of congenital cystic lung lesions. Paediatr Respir Rev 2002; 3(2):120. 2. Roberts PA, Holland AJ, Halliday RJ, Arbuckle SM, Cass DT. Congenital lobar emphysema: Like father, like son. J Pediatr Surg 2002 May, 37(5):799-801. 3. Rusakow LS, Khare S. Radiographically occult congenital lobar emphysema presenting as unexplained neonatal tachypnea. Pediatr pulmonol 2001 Sep; 32(3): 246-9. 4. Babu R, Kyle P, Spicer RD. Prenatal sonographic features of congenital lobar emphysema. Fetal Diagn Ther 2001 Jul-Aug; 16(4):200-2. 5. Quinton AE, Smoleniec JS. Congenital lobar emphysema –the disappearing chest mass: antenatal ultrasound appearance. Ultrasound Obstet Gynecol 2001 Feb; 17(2): 169-71. 6. Lacy DE, Shaw NJ, Pilling DW, Walkinshaw S. Outcome of congenital lung abnormalities detected antenatally. Acta Paediatr 1999 Apr; 88(4):454-8. 7. Van Koningsbruggen S, Ahrens F, Brockmann M, Michalk D, Rietschel E. Congenital cystic adenomatoid malformation type 4. Pediart Pulmonol 2001 Dec; 32 (6):471-5. 8. Thompson AJ, Reid AJ, Reid M. Congenital lobar emphysema occurring in twins. J Perinat Med 2000; 28(2):155-7. 9. Olutoye O, Coleman BG, Hubbard AM, Adzick NS. Prenatal diagnosis and management of congenital lobar emphysema. J Pediatr Surg 2000 May; 35 (5):792-5. 10. Karnak I, Senocak ME, Ciftci AO, Buyukpamukcu N. Congenital lobar emphysema: diagnostic and therapeutic considerations. J Pediatr Surg 1999 Sep; 34 (9):1347-51. 11. Al-Bassam A, Al-Rabeeah A, Al-Nassar S, Al-Mobaireek K, Al-Rawaf A, Banjer H. Congenital cystic disease of the lung in infants and children (experience with 57 cases). Eur J Pediatr Surg 1999 Dec; 9(6):364-8. 12. Cay A, Sarihan H. Congenital malformation of the lung. J Cardiovasc Surg (Torino) 2000 Jun; 41(3):507-10. 13. Al- Salem AH. Congenital lobar emphysema. Saudi Med J 2002 Mar; 23 (3): 335-7. 14 Thakral CL, Maji DC, Sajwani MJ. Congenital lobar emphysema: experience with 21 cases. Pediatr Surg Int 2001 Mar; 17(2-3):88-91. 15. Bappal B, Ghani SA, Chaudhary R, Sajvani MJ. Congenital lobar emphysema : a review of 10 cases. Indian J Pediatr 1996 Nov-Dec; 63(6):801-8. 16. Dogan R, Demircin M, Sarigul A, Pasaoglu I, Gocmen A, Bozer AY. Surgical management of congenital lobar emphysema. Turk J Pediatr 1997 Jan-Mar; 39(1): 3544. 17. Keidar S, Ben-Sira L, Weinberg M, Jaffa AJ, Silbiger A, Vinograd I. The postnatal management of congenital cystic adenomatoid malformation. Isr Med Assoc J 2001 Apr; 3(4):258-61. Recibido: 24 de diciembre de 2002. Aprobado: 26 de febrero de 2003. Dr. Ruperto Llanes Céspedes. Juan Lefont No.8 entre Johnson y Libertad. 10 de Octubre. Ciudad de La Habana, Cuba. T-3 Referencias bibliográficas 1. Frezza EE. Girnys RP, Silich RJ, Coppa GF. Commentary quality of care and costs containment are the hospital-based ambulatory surgery challenges for the future. Am J Med Qual 2000;15:114-8. 2. Mezei B, Chung F. Return hospitals visits and hospital readmission after ambulatory surgery. Ann Surg 1999; 230(5):721-7. 3. Patel RI, Verghese ST, Hannallah RS, Aregawi H, Patel KM. Fast tracking children after ambulatory surgery. Anesth Analg 2001; 92(4): 918-22. 4. Munro HW, Malviya S, Lauder GR, Voepel Lewis T, Tait AR. Pain relief in children following outpatient surgery. J Clin Anesth 1999; 11(3): 187-9. 5. Cloud DT. Major ambulatory surgery of the pediatric patient. En: Davis JE (ed.). Baltimorew Milliams Wilkins, 1986:367. 6. Morse TS. Pediatric out patient surgery. J Pediatric Surg 1972:283. 7. Othersen HB, Clatworthy HW, Jr: Out patient herniorraphy for infants. Am J Dis Chile 1988:78. Recibido: 23 de abril de 2003. Aprobado: 8 de julio de 2003. Dr. Arturo L Delgado Delgado. Hospital Pediátrico Universitario “San Miguel del Padrón”, San Miguel del Padrón, Ciudad de La Habana, Cuba. T-4 Referencias bibliográficas 1. Gary Cunningham F, Mac Donald PC, Grant NF, Leveno KJ, Gilstrap III LC, Hankins GDV, et al. En: Williams, Obstetricia 20, ed. Buenos Aires: Ed. Medica Panamericana, 1998: 44362. 2. Colectivo de autores. Manual de diagnóstico y tratamiento en Obstericia y Perinatología. La Habana: Ed. Ciencias Médicas, 2000: 460-70. 3. Reeder Sharon J, Martin Leonide L, Koniak D. Parto vaginal asistido con instrumentos. En: Enfermería materno-infantil. 17 ed. Mexico: Nueva Editorial Interamericana, 1995: 1007-12. 4. Carrera Macía JM. Protocolos de Obstetricia y Medicina Perinatal del Instituto Dexeaus. 2da ed. España: Salvat editores, 1988: 266-8. 5. Botella Llusiá J, Clavero Nuñez JA. Tratado de Ginecología y Obstetricia. 2da. Ed. Barcelona: Científico Médico de Barcelona, 1993: 853-888; t. 2. 6. Behrman RE, Kliegman RM, Harbin AM. Tratado de Pediatría. Nelson. 15 ed. La Habana: Ed. Ciencias Médicas, 1998: 583-4; t. 7. Ordás J. La extracción fetal mediante espátulas de Thierry. Toko Ginecol marzo 1990: 10911. 8. Perales A. La instrumentación vaginal en el sufrimiento fetal agudo. Rev Esp Obstetricia Ginecol 1998; 47: 205-10. Recibido: 3 de septiembre de 2002. Aprobado: 19 de octubre de 2002. Dra. Rosa M. Alonso Uría. Avenida 101, No. 20 804, entre Blanco y Villa Rosa, Las Granjas, Cotorro, Ciudad de La Habana, Cuba. T-5 Referencias bibliográficas 1. De Juan Martín F. Impacto de la inmunización frente a la enfermedad invasora por neumococo: vacuna neumocócica conjugada. An Esp.Pediatr 2002;57:24-30. 2. Perez AE, Dickinson FO, Baly A, Martínez R. The epidemiologycal impact of antimeningococcal B vaccination in Cuba. Mem Inst. Oswaldo Cruz 1999;94(4):433-40. 3. Dickinson F, Pérez A, Galindo MA, Quintana I. Impacto de la vacunación contra Haemophilus influenzae tipo b en Cuba. Rev Panam Salud Pública 2001;(3):169-74. 4. Dickinson FO, Pérez AE. Las meningoencefalitis bacterianas en la población infantil cubana:1998-2000. Rev Cubana Pediatr 2002;75 (2):106-14. 5. Dirección Nacional de Estadísticas. MINSAP. .Anuario Estadístico de Salud, 2001. 6. Otero Reigada MC, Pérez Tamarit D, Asensi Boted F. Meningitis bacterianas. En: Protocolos diagnósticos y terapéuticos en Pediatría. Tomo 2. .Infectología. Asociación Española de Pediatría, Madrid, 2001:149-55. 7. Sáez-Llorens X. Nuevas perspectivas en meningitis bacteriana. An Esp Pediatr 2001;54 (supl 4):401-2. 8. -----------------. Patogénesis de la meningitis bacteriana. Implicaciones terapéuticas. An Esp.Pediatr 2002;57:14-8. 9. Alvez F. Meningitis bacteriana. En: Castro Gago M. Tratamiento de las enfermedades neurológicas en niños y adolescentes. Barcelona: Ed Espaxs. 1999: 119-25. 10. Asensi Botet F. Tratamiento de las meningitis bacterianas. An Esp.Pediatr 2002;57: 19-23. 11. Saens-Llorens X, Mc Cracken GH. Antimicrobial and anti inflammatory treatment of bacterial meningitis. Infect Dis Clin North Am 1999;13:619. 12. Kaplan SL. Adjuvant therapy in meningitis. Adv Pediatr Infect Dis 1995;10:167-86. 13. Casado J. Meningitis aguda en la infancia. En: F. Rusa. Tratado de Cuidados Intensivos Pediátricos, 2 ed. Madrid: Ed Norma, 1994:888-904. 14. Martin Ancel A, García Alix, Quero J. Meningitis bacteriana: mecanismos de daño cerebral y nuevas aproximaciones terapéuticas. An Esp Pediatr 1997;47:126-34. 15. Colectivo de autores. Programa Nacional de Prevención y Control de Síndromes Neurológicos Infecciosos. La Habana: MINSAP, 1999:18-21. 16. Singhi S. Fluid restriction and intracraneal presure during bacterial meningitis: To restrict fluid or not. 10th International Congress on Infection Diseases. Singapore, 14 de marzo de 2002, Book of Abstracs,130. 17. Colectivo de autores. Guías de práctica clínica. Terapia intensiva pediátrica. La Habana: Ed Política, 2001, capítulo 4: Agua y electrólitos: 33-69. 18. ---------------------. Guías de práctica clínica. Terapia intensiva pediátrica. La Habana: Ed Política, 2001,capítulo 6: Sepsis: 89-103. 19. Llop A, Tamargo I, Ramírez M, Pérez M, Toraño G, Ramírez M, et al. Resistencia a los antimicrobianos y vigilancia microbiológica en Cuba. Rev Panamericana de Infectología, 1999; 3(Supl 1):33-40. 20. Del Valle Ortiz O, Streptoccocus pneumoniae y resistencia a los antimicrobianos. En: Moraga Llop F, editor. La enfermedad neumocócica en el niño, 1era ed. Barcelona: Prous Science, 2001: 69-79. 21. Saez-Llorens X, McCoig C, Ferris JM. Quinolone treatment for pediatric bacterial meningitis: A comparative study of trovefloxacin and ceftriaxone with or without vancomicyn. Pediatr Infect Dis J2002;21:14-22. 22. Mitchell L, Toumanen E. Vancomycin tolerant S. pneumoniae and its clinical significance. Pediatr Infec Dis.J.2001;12:531. 23. Tamargo I, Toraño G, Pérez M, Fuentes K, Llop A, et al. Susceptibilidad antimicrobiana en cepas de Haemophilus influenzae y Streptococcus pneumoniae circulantes en Cuba. Revista Latinoamericana de Microbiología 2000;42:603. 24. Craig WA. Pharmacokinetics/pharmacodynamics parameters: Rationale for antibacterial dosing of mice and men. Clin Infect Dis1998;26:1. 25. Craig WA. Relationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for cephalosporin. .Diagn Microbiol Infect Dis 1995;22:89. 26. McIntyre PB, Berkey CS, King SM. Dexamethasone as adjunctive therapy in bacterial meningitis: A metaanalysis of randomized clinical trials since 1988. JAMA 1997;278:925. Recibido: 23 de marzo de 2003. Aprobado: 4 de julio de 2003. Dr. Roberto Alvarez Fumero. Hospital Pediátrico Universitario Centro Habana. Benjumeda esq. Morales, Cerro, Ciudad de La Habana, Cuba. Email: fumero@ msp.sld.cu T-6 Referencias bibliográficas 1. Acute Respiratory infections: the forgotten pandemic. Communique from the international conference on acute respiratory infections, held in Canberra, Australia, 710 July 1997. Int J Tuberc Lung Dis 1998; 2(1):2-4. 2. McCracken GH Jr. Etiology and treatment of pneumonia. Pediatr Infect Dis J 2000;19(4):373-7. 3. Hinman A. Eradication of vaccine-preventable diseases. Annu Rev Public Health 1999;20:211-29. 4. Monto AS, Lehmann D. Acute respiratory infections (ARI) in children: prospects for prevention. Vaccine 1998;16(16):1582-8. 5. Breiman RF, Butler JC, McInnes PM. Vaccines to prevent respiratory infection: Opportunities on the near and far horizon. Curr Opin Infect Dis 1999;12:145-52. 6. Ottolini MG. Current and future use of vaccines for viral and bacterial respiratory tract infections. Curr Infect Dis Rep 2000;2(2):121-9. 7. Salgado HV. Manual de la inmunización humana. Medellín: Ed. Médica Colombiana, 2001;75-185. 8. Couch RB. Infuenza: prospects for control. Ann Intern Med 2000 Dec 19;133(12):9928. 9. Poehling KA, Edwards KM. Prevention, diagnosis, and treatment of infuenza: current and future options. Curr Opin Pediatr 2001;13(1):60-4. 10. Saito T, Tashiro M. Vaccines and therapeutics against influeza virus infections. Pediatr Int 2000;42(4):219-25. 11. Luscher-Mattli M. Influenza chemotherapy: a review of the present state of art and of new drugs in development. Arch Virol 2000;145(11):2233-48. 12. Gaillat J. What is current opinion of antiviral therapy for the flu in 2001? Rev Med Interne 2001;22(1):53-61. 13. Woodhead M, lavanchy D, Johnston S, Colman P, Fleming D. Neuraminadase inhibitors: progress in the management of influenza. Int J Clin Pract 2000;54(9):604-10. 14. Mossad SB. Prophylactic and symptomatic treatment of influeza, current and developing options. Postgrad Med 2001;109(1):97-105. 15. Prince GA. An update on respiratory suyncytial virus antiviral agents. Expert Opin Invest Drugs 2001;10(2):297-308. 16. Greenough A, Thomas M. Respiratory syncytial virus prevention: past and present strategies. Expert Opin Pharmacother 2000;(6):1195-201. 17. Kneyber MC, Moll HA, de Groot R. Treatment and prevention of respiratory syncytial virus infection. Eur J Pediatr 2000;159(6):399-411. 18. Wright PF, Karron RA, Belshe RB, Thompson J, Crowe JE, Boyce TG, et al. Temperatura-sensitive, respiratory syncytial virus vaccine candidate in infancy. J Infect Dis 2000;182(5):1331-42. 19. Kahn JS. Respiratory sincytial virus vaccine development. Curr Opin Pediatr 2000;12(3):257-62. 20. Goetsch L, Plotnicky-Gilquin H, Champion T, Beck A, Corvaia N, Stahl S, et al. Influence of administration dose and route on the immunogenicity and protective efficacy of BBG2Na, a recombinant respiratory syncytial virus subunit vaccine candidate. Vaccine 2000;18(24):2735-42. 21. Sawyer LA. Antibodies for the prevention and treatment of viral diseases. Antiviral Res 2000;47(2):57-77. 22. Shigeta S. Recent progress in antiviral chemotherapy for respiratory syncytial virus infections. Expert Opin Investig Drugs 2000;9(2):221-35. 23. McKim-Breschkin J. VP-14637 viroPharma. Curr Opin Investig Drugs 2000;1(4):4257. 24. Petrescu AL, Petica M, Barnaure F, Athanasiu P. Immunogenicity of inactiviated bacines prepared with parainfluenza viruses type 1 and type 3, administered experimentally by nasal or oral route. Rom J Virol 1998;49(1-4):97-115. 25. Haller AA, Miller T, Mitiku M, Coelingh K. Expression of the surface glycoproteins of human parainfluenza virus type 3 by bovine parainfluenza virus type 3, a novel attenuated virus vaccine vector. J Virol 2000;74(24):11626-35. 26. Muñoz FM, Englund JA. A step ahead. Infant protection through maternal immunization. Pediatr Clin Nort Am 2000;47(2):449-63. 27. Gray GC, Goswami PR, Malasig MD, Hwasworth AW, Trump DH, Ryan MA, et al. Adult adenovirus infections: loss or orphaned vaccines precipitates military respiratory disease epidemics. For the adenovirus surveillance group. Clin Infect Dis 2000;31(3):663-70. 28. Hyer RN, Howell MR, Ryan MA, Gayudos JC. Cost-effectiveness analysis of reacquiring and using adenovirus types 4 and 7 vaccines in naval recruits. Am J Trop Med Hyg 2000;62(5):613-8. 29. Hayden FG. Influenza virus and rhinovirus-related otitis media: potential for antiviral intervention. Vaccine 2000;Suppl 1:S66-70. 30. Schultz J, Dollenmaier G, Molling K. Update on antiviral DNA vaccine research (1998-2000). Intervirology 2000;43(4-6):197-217. 31. Bembridge GP, Rodriguez N, Garcia-Beato R, Nicolson C, Melero JA, Taylor G. DNA encoding the attachment (G) or fusion (F) protein of respiratory syncytial virus induces protection in the absence of pulmonary inflammation. J Gen Virol 2000;81 Pt 10:251923. 32. Wong JP, Zabielski MA, Schmaltz FL, Brownlee GG, Bussey LA, Marshall K, et al. DNA vaccination against respiratory influenza virus infection. Vaccine 2001;19(1719):2461-7. 33. Black S, Shinefield H. Issues and Challenges: Pneumococcal vaccination in pediatrics. Ped Ann 1997;26:355-60. 34. Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA. Pneumoccocal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis madia acuta. J Infect Dis 1999;1179(5):11526. 35. Klein JO. Management of otitis media: 2000 and beyond. Pediatr Infect Dis J. 2000;19(4):383-7. 36. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21 st century: global análisis of the disease burden 25 years after the use of the polysaccharide vacine and a decade after the advent of conjugates. Clin Microbiol Rev 2000;13(2):302-17. 37. Burns IT, Zimmerman RK. Haemophilus influenzae type B disease, vaccines, and care of exposed individuals. J Farm Pract 2000;49(9 Suppl):S7-13. 38. Rosenstein NE, Perkins BA. Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr Clin North Am 2000;47(2):337. 39. Kyd J, Cripps A. Nontypeable haemophilus infoluenzae: challenges in developing a vaccine. J Biotechnol 1999;73(2-3):103-8. 40. Hewlett EL. Pertussis: current concepts of pathogenesis and prevention. Pediatr Infect Dis J 1997;16:S78-84. 41. AAP. Committee on infectious diseases. Acellular pertussis vaccine: recommendations for use as the initial series in infant and children. Pediatrics 1997;99:282-8. 42. Brandt ER, Good MF. Vaccine strategies to prevent rheumatic fever. Immunol Res 1999;19:89-103. 43. Dale JB. Group Streptococcal vaccines. Infect Dis Clin North Am 1999;13:227-43. Recibido: 4 de marzo de 2001. Aprobado: 9 de septiembre de 2002. Prof. Dr. Roberto Razón Behar. Hospital Pediátrico Universitario “William Soler”. San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba. T- 7 Referencias bibliográficas 1. Stites D, Terr A, Parslow T. Basic and clinical immunology. 8. ed. Connecticut: Appleton and Lange, 1994:263. 2. Rosen FS, Cooper MD, Wedgwood RJP. The primary inmunodeficiencies. N Engl J Med 1995; 333(7)431-40. 3. Bruton OC. Agammaglobulinemia. Pediatrics 1952; 9:722-8 4. Primary Immunodeficiency diseases. Report WHO Scientific Group. Clin Exp Immunol 1999;118 (Suppl) 1. 5. Behrman RE, Kliegma RM, Arvin AM. Tratado de Pediatría Ed. McGraw Hill Interamericana 1998:720. 6. Buckley RH. Immunodeficiency Diseases. JAMA. 1992;268(20):2797-06. 7. Gungor T, Buhring I, Cremer R, Gartenschlager M, Zielen S. [Pathogenesis, diagnosis, clinical and therapeutic aspects of ataxia telangiectasia] Klin Paediatr 1997 SepOct;209(5):328-35. 8. Nelson DL, Kurman CC. Molecular Genetic analysis of the primary immunodeficiency Disorders. Ped Clin North America 1994; 41(4):657-64. 9. Davies EG. Infection in patients with primary immunodeficiencies diseases. Curr Op Infect Dis 2000;13(4):349-53 10. Ballow M. Primary Immnunodeficiency. Antibody deficiency. J All Clin Immunol 2002;109(4):581-91. 11. Stiehm ER. Immunological disorders in infants and children. 4 ed. Philadelphia: WB Saunders, 1996: 201-52. 12. Fontán G. Inmunodeficiencias primarias. Clínica y formas variantes. Allergol et Inmunopathol.2001; (3): 101-125. 13. Cunningham-Rundles C. Common Variable Immunodeficiency. Curr Allergy Asthma Rep 2001; 1(5):421-9. 14. Nysrad W, Skrondal A, Magnus P. Day care attendance, recurrent respiratory tract infection and asthma. Int J Epidemiol 1999; 28(5):882-7. 15. Celedon JC, Litonjua AA, Weis ST, Gold DR. Day care attendance in the first year of life and illnesses of the upper and lower respiratory tract in children with a familial history of atopy. Pediatrics 1999;104(pt 1):495-500. 16. Antaya RJ, Gardner ES, Bettencourt MS, Daines M, Denise Y, Uthaisangsook S, Buckley RH, Prose NS. Cutaneous complications of BCG vaccination in infants with immune disorders: two cases and a review of the literature. Pediatr Dermatol 2001 MayJun;18(3):205-9. 17. Cunningham-Rundles C. Hematologic complications of primary immunodeficiency. Blood Rev 2002; 16(1): 61-4. 18. Abonia JP. Common Variable Immunodeficiency. All Asthma Proc 2002; 23 (1):53-7 19. Mackay IR, Ritts RE. Use and abuse of 8 widely-used diagnostic procedures in clinical immunology: a WHO Memorandum. Bullettin of the WHO1981;59(5):717-28. 20. Bloch KJ, Buckley RH, Kohler PF. Diagnostic laboratory immunology: a subspecialty that encompasses clinical as well as laboratory immunology. J Allergy Clin Immunol 1991;Dec;88(6):961-3. 21. Buckley RH. Primary celular imunodeficiency. J All Clin Immunol 2002;109(5pt1):747-7. 22. -------------------. Breakthroughs in the understanding and therapy of Primary Immunodeficiency. Ped Clin North Am 1994;41(4) 665-90. 23. Culver KW, Blaese RM. Gene therapy for Immunodeficiency Disease. New Concepts in Immunodeficiency Diseases. Ed by S Gupta and C. Griscelli.1993:428. 24. Otsu M, Wanda T. Gene therapy for Primary Immunodeficiency. Current Opin Infect Dis. 2001; 1(6): 497-501. 25. Myers LA, Patel DD, Puck JM, Buckley RH. Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. Blood 2002 Feb 1;99(3):872-8. 26. Patel DD, Gooding ME, Parrott RE, Curtis KM, Haynes BF, Buckley RH. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000 May 4 ;342(18):1325-32. 27. Buckley RH. Advances in the understanding and treatment of human severe combined immunodeficiency. Immunol Res 2000;22(2-3):237-51. 28. Eley BS, Hughes J, Cooper M, Pienaar S, Beatty DW. Primary immunodeficiency diseases at Red Cross War Memorial Children Hospital. SAMJ 1997; 87(12): 1684-8. 29. Giraldo P. Inmunodeficiencias secundarias. Allergol et Inmunopathol.2001; (3): 155-161. 30. Klein M. CVI newswatch, 1999;issue No.1:1-3. 31. CLIC-AAAAI. Practice parameters for the diagnosis and management of immunodeficiency. Ann Allergy Asthma and Immunology. 1996;76(3):282-94. 32. Programme of control of Acute respiratory Infections. Fourth. Programme Report 1988 1989. WHO, ARF, 1992; 90: 7 - 32. 33. Wahlgren DR, Hovell MF, Meltzer EO, Meltzer SB. Involuntary smoking and asthma. Curr Opin Pulm Med 2000 Jan;6(1):31-6. 34. Corbo GM, Forastiere F, Dell'Orco V, Pistelli R, Agabiti N, De Stefanis B, Ciappi G, Perucci . Effects of environment on atopic status and respiratory disorders in children. J Allergy Clin Immunol 1993 Oct;92(4):616-23. 35. Infante-Rivard C. Childhood asthma and indoor environmental risk factors. Am J Epidemiol 1993 Apr 15; 137(8):834-44. 36. Forastiere F, Agabiti N, Corbo GM, Dell'Orco V, Porta D, Pistelli R, Levenstein S, Perucci CA. Socioeconomic status, number of siblings, and respiratory infections in early life as determinants of atopy in children. Epidemiology 1997 Sep;8(5):566-70. 37. Lang T1 Lafaix C, Fassin D , Arnault. Y, Salmon B. Acute respiratory infections : a longitudinal study of 151 children in Burquina - Faso. Int. J. Epidemiol 1986 ; 15 4: 553 - 60 . 38. Ballard TJ, Neuman CG. The Effects of Malnutrition , Parenteral Literacy and Household Crowding on Acute Lower Respiratory . Infections in young Kenyan Children Journal of Tropical Pediatrics 1995; 41 : 8 -12. 39. Tupasi TE Malnutrition and Acute respiratory tract infections in Filipino children. Rev. Infect. Dis 1990; 12 suppl 8: 1047 - 54. 40. Nystad W, Skrondal A, Magnus P. Day care attendance, recurrent respiratory tract infections and asthma. Int J Epidemiol 1999 Oct; 28(5):882-7 41. Deb S. Acute respiratory disease survey in Tripura in case of children below five years of age. J Indian Med Assoc 1998 Apr; 96(4):111-6 . 42. Castro-Rodríguez JA, Holberg CJ, Wright AL, Halonen M, Taussig LM, Morgan WJ. Association of radiologically ascertained pneumonia before age 3 yr with asthmalike symptoms and pulmonary function during childhood: a prospective study. Am J Respir Crit Care Med 1999 Jun;159(6):1891-7 43. Youssef Fasheh W, Esquinas Rychen G. The middle lobe syndrome in pediatrics. A study of 27 cases]. An Esp Pediatr 1998 Dec;49(6):582-6 . 44. Pons Pedro A. Enfermedades del Aparato Respiratorio / Pedro A. Pons.- Barcelona: Ed. SALVAT, 1968: 501. 45. del Rosario JF, Orenstein SR. Evaluation and management of gastroesophageal reflux and pulmonary disease. Curr Opin Pediatr 1996 Jun;8(3):209-15 . 46. Guill MF. Respiratory Manifestations of Gastroesophageal Reflux in Children. J of Asthma. 1995; 32(3), 173-189. 47. Anuario Estadístico 1998. Dirección Nacional de Estadística. MINSAP. La Habana, CUBA. Recibido: 10 de abril de 2003. Aprobado: 26 de junio de 2003. Dra. María Victoria Guntiñas Zamora. Avenida de la Ceiba esq. a 2da. Casino Deportivo. Ciudad de La Habana, Cuba. Habana 34. Cod. Postal 13400. T-8 Referencias bibliográficas 1. Lake CL. Pediatric cardiac anesthesia. Second Edition. Norwalk: Ed. Appleton & Lange, 1993 2. Gregory GA. Pediatric anesthesia. 4th ed. New York: Ed. Churchill-Livingstone, 2002. 3. Kaplan J. Cardiac anesthesia. Fourth Edition. Philadelphia: Ed. Churchill- Livingstone, 1999. 4. De la Parte PL, Hernández SB, Pérez PI. Anestesia en los defectos septales. Rev Cubana Pediatr 1995; 67(3):174 -80. 5. De la Parte PL, Hernández SB, Pimienta P. Anestesia en la comunicación interventricular del lactante. Rev Cubana Cir 1995;34 (1):31-40. 6. De la Parte PL. Anestesia en el síndrome de Down con canal auriculoventricular común. Rev Cubana Pediatr 1995;67(2):97-102. 7. Barash GP. Clinical Anesthesia. 4th ed. Philadelphia: Ed. Lippincott Williams & Wilkins, 2001. 8. De la Parte PL, Hernández SB, Carballés GF. Anestesia en la ventana aortopulmonar. Rev Cubana Pediatr 2001;73(2):81-5. 9. De la Parte PL. Anestesia en la coartación de la aorta. Rev Cubana Pediatr 2001; 73(4):21523. 10. Gal TJ. Reactive Airway disease: Anesthetic perspectives. IARS 2002 Review Course Lectures. Suppl. to Anesthesia & Analgesia 2002(March):45-53. 11. Gruber EM, Laussen PC, Casta A. Stress response in infants undergoing cardiac surgery: a randomized study of fentanyl bolus, fentanyl infusion, and fentanyl-midazolam infusion. Anesth & Analg 2001;92(4):882-90. 12. Duncan HP, Cloote A, Weir PM. Reducing stress response in the pre-bypass phase of open heart surgery in infants and young children: a comparison of different fentanyl doses. British J Anaesth 2000;84:556-64. 13. Lake CL. Fast Tracking in paediatric Cardiac anaesthesia: An update. Annals Cardiac Anaesthesia 2002;5:203-08. 14. De la Parte PL. Valor del Rocuronio en la intubación nasotraqueal del niño cardiópata. Rev Cubana Pediatr 2002;74(2):145-50. 15. Andropoulos D, Bent S. The optimal length of insertion of central venous catheters for pediatric patients. Anesth Analg 2001;93:883-6. Recibido: 29 de julio de 2003. Aprobado: 29 de septiembre de 2003. Dr. Lincoln de la Parte Pérez. Hospital Pediátrico Universitario “William Soler”. San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba. Correo: lincoln.delaparte@infomed.sld.cu T-9 Referencias bibliográficas 1. Ohtahara S, Ishida T, Oka E, Yamatogi Y, Inoue H. On the specific age-dependent epileptic syndrome. The early-infantile epileptic encephalopathy with suppression-burst. No-ToHattatsu (Tokyo) 1976;8:270-80. 2. Engel J Jr. ILAE Commission Report. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: Report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42:1-8. 3. Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E, Inoue H. L’encéphalopathie épileptique infantile précoce avec “suppression-burst”. En Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Les syndromes épileptiques de l’enfant et de l’adolescent. 2e ed. London: John Libbey,1992: 25-34. 4. Yelin K, Alfonso I, Papazian O. Síndrome de Ohtahara. Rev Neurol 1999;29:340-2. 5. Ohtahara S, Ohtsuka Y, Yamatogi Y, Oka E. The early-infantile epileptic encephalopathy with suppression- burst:developmental aspects. Brain Dev 1987;9: 371-6. 6. Yamatogi Y, Ohtahara S. Early –infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases. Brain Dev 2002;24:13-23. 7. Hoefer PFA, de Napoli RA, Lesse S. Periodicity and hypsarrhythmia in the EEG. Arch Neurol 1963;9:424-36. 8. Ohtahara S, Yamatogi Y. Evolution of seizures and EEG abnormalities in childhood onset epilepsy. En Wada JA, Ellingson RJ, eds. Clinical neurophysiology of epilepsy EEG handbook (revised series, vol 4 ). Amsterdam: Elsevier, 1990:457-77. 9. Bermejo AM, Martin VL, Arcas J, Pérez-Higueras A, Morales C, Pascual Castroviejo I. Early infantile epileptic encephalopathy: a case associated with hemimegalencephaly. Brain Dev 1992;14:425-8. 10. Robain O, Dulac O. Early epileptic encephalopathy with suppression bursts and olivarydentate dysplasia. Neuropediatrics 1992;23:162-4. 11. Campistol J, García-García JJ, Lobera E, Sanmarti FX, Conill J, Fernández-Alvarez E. Síndrome de Ohtahara: una forma de epilepsia edad-dependiente. Rev Neurol 1997;25:2124. 12. González de Dios J, Moya M, Pastore C, Izura V, Carratalá F. Encefalopatía epiléptica infantil precoz y encefalopatía glicinémica. Rev Neurol 1997;25:1916-18. 13. Williams AN, Gray RG, Poulton K, Ramani P, Whitehouse WP. A case of Ohtahara syndrome with cytochrome oxidase deficiency. Dev Med Child Neurol 1998;40:568-70. 14. Trinka E, Rauscher C, Nagler M, Moroder T, Ladurner G, Irnberger E, et al. A case of Ohtahara syndrome with olivary-dentate dysplasia and agenesis of mamillary bodies. Epilepsia 2001;42:950-3. 15. Itoh M, Hanaoka S, Sasaki M, Ohama E, Takashima S. Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts: comparison with those of early myoclonic encephalopathy and West syndrome. Brain Dev 2001;23:721-6. 16. Dulac O. Epilepsies et convulsions de l’enfant. Encycl Méd Chir Pédiatrie. Paris: Elsevier, 1998:1-26. 17. Ohno M, Shimotsuji Y, Abe J, Shimada M, Tamiya H. Zonisamide treatment of early infantile epileptic encephalopathy. Pediatr Neurol 2000;23:341-4. 18. Aicardi J, Goutières F. Encéphalopathie myoclonique néonatale. Rev EEG Neurophysiol 1978;8:99-101. 19. Harris R, Tizard JPM. The electroencephalogram in neonatal convulsions. J Pediatr 1960;57:501-20. 20. Dreyfus-Brisac C, Monod N. Electro-clinical studies of status epilepticus and convulsions in the newborn. En: Kellaway P, Petersen I, eds. Neurological and electroencephalographic correlative studies in infancy. New York: Grune and Stratton, 1964:251-72. 21. Pozo D, Camejo A, Moreno O. The diagnostic and prognostic value in perinatal asphyxia. Z Klin Med 1990;22:1979-80. 22. Aicardi J. Encéphalopathie myoclonique précoce (encéphalopathie myoclonique néonatale). En : Roger J, Bureau M, Dravet C, Dreifuss FE, Perret A, Wolf P, eds. Les syndromes épileptiques de l’enfant et de l’adolescent.2e ed. London: John Libbey, 1992:13-23. Recibido: 3 de junio de 2003. Aprobado: 28 de julio de 2003. Dra. Albia J. Pozo Alonso. Servicio de Neuropediatría. Hospital Pediátrico Universitario “William Soler”. San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba. Correo electrónico: albiap@infomed.sld.cu T-10 Referencias bibliográficas 1. Avila ML, Odio CM. Enfermedad por arañazo de gato (linforreticulosis benigna por inoculación) en: Meneghello J, Fanta E, Paris E, Puga TF. Pediatría. 5a ed. Buenos Aires: Ed. Panamericana 1997; 849-51. 2. Schutze GE. Diagnóstico y tratamiento de las infecciones por Bartonella henselae. .Pediatr Infect Dis J 2000; 16: 1185-8. 3. Wear DJ, Margilein AM, Hadfield TL, Fisher GW, Schlagel CJ, King FM. Cat scratch disease: a bacterial infection. Science 1983; 221: 1403-5. 4. Brenner DJ, O’Connor SP, Winkler HH, Steirgerwait AG. Proposal to unify the genera Bartonella and vinsonii comb. nov, Bartonella henselae comb. nov, and Bartonella elizabethae comb. nov. and remove the family Bartonellaceae from the order Rickettsiales. In J Syst bacterial 1993; 43: 777-86. 5. Cruz AM, Vila AJ, Saa Requejo, Muñoz JC. Enfermedad por arañazo de gato. Centro de Salud 2001; +9: 152-5. 6. Frandson JM, J Rawlings, Burgess CR, Hendricks KA. Cat scratch disease in Texas. Infect Med 2000; 17: 690-94. 7. Giladi M, Avidor B. Cat scratch disease. N Eng J Med 1999; 340: 108. 8. Whitman BW, Krafte-Jacobs B. Cat scratch disease associated whit pleural effusions and encephalopathy in a child. Respiration 1995; 62: 171-3. 9. Anlemnmes P, Leroy J, Estavoyer JM, Destuynder O, Aubert D, Vienet G, et al. A little know cause of persistent fever and granulomatous hepatitis in children: cat scratch disease. Arch Pediatr 1995; 2: 657-661. 10. Abbasi S. pulmonary manifestation of cat scratch disease. Pediatr Infect Dis J 1995; 14: 5478. 11. Smith DL. Cat scratch disease and related clinical syndromes. Am Fam Physician 1997; 55: 1783-9, 1794. 12. Donnelly A, Hendricks G, Martens S, Strovers C, Wiemerslage S, Thomas PA. Cytologic diagnosis of cat scratch disease (CSD) by fine-needle aspiration. Diagnostic Cytopathology 1995; 13:103-6. 13. Ferrer R. Linphadenopathy: differential diagnosis and evaluation. Am Fam Physician 1998; 58:1313-22. 14. Enfermedad por arañazo de gato. Diagnóstico mediante reacción en cadena de la polimerasa. Actas Dermo-Sifiliográficas 2000; 91: 395-9. 15. Segura-Corrales J, Bosch-Aparici X, Bosch-Mestre J, Sole-Arques M, Martínez-Orozco F. Enfermedad por arañazo de gato. Presentación de dos casos familiares con seguimiento serológico y discusión de métodos diagnósticos. Rev Clin Esp 1998; 198: 360-3. 16. Bolhmann BJ. Treatment of cat scratch disease (comment, letter). N Eng J Med 1999; 340. 1842. 17. Walterspiel JN. Treatment of cat scratch disease (letter). N Eng J Med 1999; 340:1842-3. 18. Giladi M, Ephros M. Treatment of cat scratch disease (letter). N Eng J Med 1999; 340:1843. 19. Bodino JA. Enfermedad recurrente por arañazo de gato. En: Datos interesantes publicados recientemente. Revista de Enfermedades Infecciosas en Pediatría, 1999; vol XI (49): 293. Recibido: 15 de abril de 2003. Aprobado: 21 de julio de 2003. Dra. Ileana Alvarez Lam. Hospital Pediátrico Universitario “William Soler”, San Francisco y Perla, Altahabana, Boyeros, Ciudad de La Habana, Cuba.